The University of Southampton
University of Southampton Institutional Repository

Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1

Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1
Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1

Inhibitory receptors of the human leukocyte immunoglobulin-like receptor family are constitutively expressed on all myeloid cell types and regulate their functional activity. We demonstrate that ligation of the human leukocyte antigen class I-specific receptor LILRB1, during the differentiation of monocytes to dendritic cells in vitro, results in increased expression of the nuclear factor κB inhibitor protein ABIN1 (also known as TNIP1). Similarly increased expression of ABIN1/TNIP1 was observed in the "immunosuppressive" monocyte populations of patients with non-Hodgkin lymphoma ex vivo. Reducing expression of ABIN1/TNIP1 using small interfering ribonucleic acid allows dendritic cells and immunosuppressive monocytes to respond to stimulation by allowing nuclear factor κB translocation to the nucleus (P < 0.001), increasing cell surface expression of antigen presentation and costimulatory molecules (P < 0.01), increasing phagocytic capacity (P < 0.001), secreting proinflammatory cytokines (P < 0.01), and an increasing ability to stimulate T cell responses (P < 0.05). Our study, therefore, identifies an important functional role for ABIN1/TNIP1 in mediating the effects of LILRB1 ligation-induced inhibitory effects on immune responses. Our findings suggest that inhibiting the LILRB1-ABIN1/TNIP1 pathway in antigen-presenting cells could be a therapeutic approach to stimulate antitumor immune responses. Conversely, stimulation of the pathway may also ameliorate autoimmune diseases in which TNIP1 is a susceptibility gene.

0741-5400
737-746
Khanolkar, Rahul C
db2205d9-b70d-4d1b-bae0-987b92888c80
Kalogeropoulos, Michail
7bf89ef4-3e77-4486-ac03-6d644d0a60ad
Lawrie, Alistair
89f1ec6f-f050-48a2-be62-76152311ec2f
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36
Vickers, Mark A
4c143039-bf61-4e70-9915-a93e237025eb
Young, Neil T
420c5bc3-494e-4840-9af2-dc1b081291b1
Khanolkar, Rahul C
db2205d9-b70d-4d1b-bae0-987b92888c80
Kalogeropoulos, Michail
7bf89ef4-3e77-4486-ac03-6d644d0a60ad
Lawrie, Alistair
89f1ec6f-f050-48a2-be62-76152311ec2f
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36
Vickers, Mark A
4c143039-bf61-4e70-9915-a93e237025eb
Young, Neil T
420c5bc3-494e-4840-9af2-dc1b081291b1

Khanolkar, Rahul C, Kalogeropoulos, Michail, Lawrie, Alistair, Roghanian, Ali, Vickers, Mark A and Young, Neil T (2016) Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1. Journal of Leukocyte Biology, 100 (4), 737-746. (doi:10.1189/jlb.1A0915-420RRR).

Record type: Article

Abstract

Inhibitory receptors of the human leukocyte immunoglobulin-like receptor family are constitutively expressed on all myeloid cell types and regulate their functional activity. We demonstrate that ligation of the human leukocyte antigen class I-specific receptor LILRB1, during the differentiation of monocytes to dendritic cells in vitro, results in increased expression of the nuclear factor κB inhibitor protein ABIN1 (also known as TNIP1). Similarly increased expression of ABIN1/TNIP1 was observed in the "immunosuppressive" monocyte populations of patients with non-Hodgkin lymphoma ex vivo. Reducing expression of ABIN1/TNIP1 using small interfering ribonucleic acid allows dendritic cells and immunosuppressive monocytes to respond to stimulation by allowing nuclear factor κB translocation to the nucleus (P < 0.001), increasing cell surface expression of antigen presentation and costimulatory molecules (P < 0.01), increasing phagocytic capacity (P < 0.001), secreting proinflammatory cytokines (P < 0.01), and an increasing ability to stimulate T cell responses (P < 0.05). Our study, therefore, identifies an important functional role for ABIN1/TNIP1 in mediating the effects of LILRB1 ligation-induced inhibitory effects on immune responses. Our findings suggest that inhibiting the LILRB1-ABIN1/TNIP1 pathway in antigen-presenting cells could be a therapeutic approach to stimulate antitumor immune responses. Conversely, stimulation of the pathway may also ameliorate autoimmune diseases in which TNIP1 is a susceptibility gene.

Text
__filestore.soton.ac.uk_users_hfc1v09_mydesktop_Roghanian_Final manuscript.docx - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Final manuscript
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 6 April 2016
e-pub ahead of print date: 29 April 2016
Published date: October 2016
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 402968
URI: http://eprints.soton.ac.uk/id/eprint/402968
ISSN: 0741-5400
PURE UUID: 2e179bbe-4fa5-4c50-8659-f7407dbeae7a
ORCID for Ali Roghanian: ORCID iD orcid.org/0000-0003-1316-4218

Catalogue record

Date deposited: 21 Nov 2016 11:54
Last modified: 15 Mar 2024 03:34

Export record

Altmetrics

Contributors

Author: Rahul C Khanolkar
Author: Michail Kalogeropoulos
Author: Alistair Lawrie
Author: Ali Roghanian ORCID iD
Author: Mark A Vickers
Author: Neil T Young

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×